Advertisement
Screener

Calliditas Therapeutics AB Auditors Remuneration

Calliditas Therapeutics AB Auditors Remuneration

Calliditas Therapeutics AB reported Auditors Remuneration of SEK 21.85 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-24.

Discontinued › Notes

ifrs-full:AuditorsRemuneration · last filed 2024-04-24

Period endAuditors Remuneration 12 month
2023-12-3121.85M SEK
20-F · filed 2024-04-24
2022-12-3116.74M SEK
20-F · filed 2024-04-24
2021-12-3110.61M SEK
20-F · filed 2024-04-24
2020-12-3110.98M SEK
20-F · filed 2023-04-26
2019-12-314.09M SEK
20-F · filed 2022-04-27
2018-12-312.37M SEK
20-F/A · filed 2022-01-14